Epidermal growth factor receptor (EGFR) is one of the targeted molecular markers in many
cancers including the lung malignancy. Genetic modifications such as deletions, insertions …

Lung cancer is the world's leading cause of cancer-related deaths. Epidermal growth factor
receptor (EGFR) is one of the critical oncogenes and plays a significant role in tumor …

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …

Introduction Testing for the epidermal growth factor receptor (EGFR) gene mutations
requires considerable multidisciplinary experience of clinicians (for appropriate patient …

Background Epidermal growth factor receptor (EGFR) represents an important molecular
target in the treatment of lung adenocarcinomas; many anti-EGFR therapies are approved …

EGFR mutation frequencies in unselected Caucasian populations are unknown. This study
assesses the prevalence of EGFR mutations in an unselected population‐based cohort, and …

1534 Background: The epidemiological, multicenter prospective study (NCT01185314;
PIONEER) assessed EGFR mutation (M) rates in pts from Asia with newly diagnosed …

Introduction: PIONEER (NCT01185314) was a prospective, multinational, epidemiological
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …

Aims Activating mutations in the gene encoding epidermal growth factor receptor (EGFR)
can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with …

Background The authors sought to define clinicopathologic features associated with
mutations of the epidermal growth factor receptor (EGFR) gene in non–small cell lung …